Hydrogen sulfide, a potential novel drug, attenuates concanavalin A-induced hepatitis

30Citations
Citations of this article
13Readers
Mendeley users who have this article in their library.

Abstract

Results: Aspartate aminotransferase, alanine aminotransferase, and pathological damage were significantly ameliorated by NaHS pretreatment. NaHS pretreatment significantly reduced the levels of interleukin-6 and tumor necrosis factor-α compared with those of the Con A group. The expression of Bcl-2, Bax, Beclin-1, and LC3-2, which play important roles in the apoptosis and autophagy pathways, were also clearly affected by NaHS. Furthermore, NaHS affected the p-mTOR and p-AKT. Conclusion: H2S attenuates Con A-induced acute hepatitis by inhibiting apoptosis and autophagy, in part, through activation of the PtdIns3K-AKT1 signaling pathway. Background: Hydrogen sulfide (H2S) is known to exert anti-inflammatory properties. Apoptosis and autophagy play important roles in concanavalin A (Con A)-induced acute hepatitis. The purpose of this study was to explore both the effect and mechanism of H2S on Con A-induced acute hepatitis. Methods: BALB/c mice were randomized into sham group, Con A-injection group, and 14 µmol/kg of sodium hydrosulfide (NaHS, an H2S donor) pretreatment group.

Author supplied keywords

Cite

CITATION STYLE

APA

Cheng, P., Chen, K., Xia, Y., Dai, W., Wang, F., Shen, M., … Guo, C. (2014). Hydrogen sulfide, a potential novel drug, attenuates concanavalin A-induced hepatitis. Drug Design, Development and Therapy, 8, 1277–1286. https://doi.org/10.2147/DDDT.S66573

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free